Search Results

Listing of needle disposal sites in California

Listing of needle disposal sites in California

Listing of sites to dispose of needles and syringes, and medication

Listing by county of places to dispose of needles, syringes and other items

CalRecylce
1001 I Street--P.O. Box 4025
Sacramento, CA 95812
(800) 732-9253
Resource Area: local
Updated: 10/03/2017  [ 52373 ] 

Diabetes Coordinator

Diabetes Coordinator

Tsehootsooi Medical Center diabetes program offers DSME/MNT education to self empowerment 1:1, group, inpatient and weekly classes.

Tsehootsooi Medical Center is an Accredited Diabetes Program by American Association of Diabetes Educators (AADE).
DSME program staffs 3 Registered Nurses/Diabetes Educators and 7 Diabetes Pharmacy
MNT program with 1 Registered Dietician
Health technician who delivers health education to our local community in English and Navajo Language
Diabetes Coordinator, BSN, CDE who oversees the Special Diabetes Program for Indians (SDPI) grant and clinic/hospital and outreach diabetes educational services for our community.
DM Program hours of operation: Monday - Friday 9am to 4pm.

Tsehootsooi Medical Center, Fort Defiance, AZ
Hwy. 12 & 7
Fort Defiance, AZ 86504
(928) 729-8467
Resource Area: local
Updated: 06/08/2014  [ 57345 ] 

Wisconsin Public Health Information & Referral On-Line Resource Directory

Wisconsin Public Health Information & Referral On-Line Resource Directory

Click on website icon to access resource directory for the Maternal and Child Health Hotline, Wisconsin First Step, and the Services Hotline for Women, Children and Families.

Our team of Information and Referral Specialists (database focus) and a Referral Database Coordinator works year round on updating our database of health and human services. Entries in the database are updated every day as we learn about changes. Information and Referral Specialists continually check resources and contacts to verify changes to ensure that our data is as accurate and up-to-date as possible.

Wisconsin Public Health Information & Referral
Online Directory Managed by
La Crosse, WI 54601
Resource Area: statewide
Updated: 09/09/2014  [ 57520 ] 

Local diabetes assistance and support

Local diabetes assistance and support

The South Coast Diabetes Association is here to support, educate & serve our community.

Here on the Southern Oregon Coast, we have a wonderful network of caring volunteers, diabetes educators, nurses, doctors, dietitians & businesses that continually support our cause to help everyone whose life has been impacted by diabetes. The South Coast Diabetes Association is here to support, educate & serve our community. All funds stay locally to benefit our community. We focus on education but also help with medication & supplies for diabetic care. We also send kids to diabetes camp. Together we can grow a healthier Community! Please Join Us!!

South Coast Diabetes Association
162 North 2nd (mail only)
Coos Bay, OR 97420
(541) 756-9054
Resource Area: local
Updated: 05/18/2015  [ 57871 ] 

Glycemia Reduction Approaches in Diabetes (GRADE) Research Study

Glycemia Reduction Approaches in Diabetes (GRADE) Research Study

Find us at http://gradestudy.com/

MedStar Health Research Institute Recruiting for Long-term Research Study of Diabetes Drug Efficacy

Hyattsville, Md. – MedStar Health Research Institute is still looking for volunteers to take part in a research study comparing the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes. The project is called the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) study.

If metformin is not enough to help manage type 2 diabetes, a person’s doctor may add one of several other drugs to lower glucose (blood sugar). But while short-term studies have shown the efficacy of different drugs when used with metformin, there have been no long-term studies of which combination works best and has fewer side effects.

“Type 2 diabetes progresses slowly, over a long period of time,” said Barbara Linder, M.D., Ph.D., the GRADE project officer at the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health. “This study will help us understand how different combinations of medications affect the disease over time, and ultimately help physicians make better choices for their patients’ long-term care.”

The research study is comparing the drug effects on glucose levels, adverse effects, diabetes complications and quality of life over an average of nearly five years.

GRADE aims to enroll about 5,000 patients. MedStar investigators and investigators at 36 other study sites are seeking people diagnosed with type 2 diabetes within the last ten years. They may be on metformin, but not on any other diabetes medication. During the research study, all participants will take metformin, along with a second medication randomly assigned from among four classes of medications, all approved for use with metformin by the U.S. Food and Drug Administration.

Three of the classes of medications increase insulin levels. They are: sulfonylurea, which increases insulin levels directly; DPP-4 inhibitor, which indirectly increases insulin levels by increasing the effect of a naturally occurring intestinal hormone; and GLP-1 agonist, which increases the amount of insulin released in response to nutrients. The fourth type of medication is a long-acting insulin.

Participants will have their diabetes medications managed free of charge through the research study, including at least four medical visits per year, but will receive other health care through their own providers.

“What differentiates GRADE from previous studies is that it will perform a head-to-head comprehensive comparison of the most commonly used drugs over a long period of time,” said David M. Nathan, M.D., of Massachusetts General Hospital, Boston. Nathan and John Lachin, Sc.D., of The George Washington University, Washington, D.C., are co-principal investigators.

“In addition to determining which medications control blood glucose levels most effectively over time, we hope to examine individual factors that are associated with better or worse response to the different medications,” Nathan said. “This should provide understanding of how to personalize the treatment of diabetes.”

GRADE (ClinicalTrials.gov number: NCT01794143) is supported under NIH grant U01DK098246. Additional support in the form of donation of supplies comes from the National Diabetes Education Program, Sanofi-Aventis, Bristol-Myers Squibb, Novo Nordisk, Merck, BD Medical and Roche Diagnostics.

Learn more about the study at https://grade.bsc.gwu.edu.

To find out if you are eligible to enroll, email GRADE@medstar.net or call 301-560-2915.

About MedStar Health Research Institute
MedStar Health Research Institute (MHRI) provides scientific, administrative and regulatory support for research programs throughout MedStar Health, the largest healthcare provider in the
Maryland and Washington, DC regions. MHRI’s expertise includes translational research into disease prevention, diagnosis and treatment. These programs complement the key clinical services and teaching programs in the ten MedStar hospitals and other MedStar Health entities. Visit us at medstarresearch.org.

MedStar Community Clinical Research Center @MedStar Health Research Institute
6525 Belcrest Rd.
Hyattsville, MD 20782
(301) 560-2915
Resource Area: local
Updated: 11/24/2015  [ 61049 ] 

Set your location then browse or search for resources in your area.

Close
My Location
Zip Code
Search Resources
or Browse Categories on Left